The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 06, 2021

Filed:

Dec. 05, 2016
Applicant:

Chimera Bioengineering, Inc., Menlo Park, CA (US);

Inventors:

Benjamin Wang, Menlo Park, CA (US);

Gusti Zeiner, Pacifica, CA (US);

Assignee:

Chimera Bioengineering, Inc., Menlo Park, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); C12N 5/10 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 35/28 (2015.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 35/17 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); C07K 16/2866 (2013.01); C07K 16/2896 (2013.01); C12N 5/10 (2013.01); A61K 35/28 (2013.01); A61K 2035/124 (2013.01); C07K 2317/622 (2013.01); C07K 2319/03 (2013.01); C07K 2319/74 (2013.01); C12N 2310/12 (2013.01);
Abstract

In an aspect, the present invention relates generally to the field of treating disease with CAR devices, Smart CAR devices, DE CAR devices, and/or Smart-DE CAR devices. The present invention also relates generally to the genetic modification of cytotoxic T-lymphocytes to reduce target cell killing by apoptosis and/or increase production of lytic proteins at desired times. In an aspect, the invention relates to the use of these genetically modified T-lymphocytes and/or natural killer cells with CAR devices, Smart CAR devices, DE CAR devices, and/or Smart-DE CAR devices to enhance the immune response against a disease.


Find Patent Forward Citations

Loading…